American Journal of Hematology · 2004 · 30 citations · 6 references
MedicineHematologyImmunologyChemotherapyHematopathologyImmunopathologyCytokine-mediated PathologyHematologic DisordersHematologic MalignanciesHematologic PathologyLeukocyte DisordersNeutrophil BiologyAcute Febrile IllnessAcute Leukemia ChemotherapyGranulocyte Colony-stimulating Factor AdministrationHematologic Cytokine DisordersHematopoietic Disorders
Sweet's syndrome is an acute febrile neutrophilic dermatosis that is a known complication of the administration of filgrastim, a drug that causes increased neutrophil proliferation and differentiation. This complication has not previously been reported during treatment with sargramostim, a hematopoietic cytokine with activity that overlaps filgrastim. We report a case of Sweet's syndrome in association with sargramostim treatment following chemotherapy for acute myelogenous leukemia. A suspected second episode occurred after subsequent chemotherapy and sargramostim treatment. Physicians should be aware of this possible association because the signs and symptoms of Sweet's syndrome are easily mistaken as being due to infection.
6
Molecular physiology of granulocyte-macrophage colony-stimulating factor
J. D. Gasson · Blood · 1991 · 589 citations · Full text
Molecular physiology of granulocyte-macrophage colony-stimulating factor
JM Rowe, J. W. Andersen, Mazza Jj et al. · Blood · 1995 · 448 citations · Full text
Medicine, Hematology, Oncology +16
Molecular analysis of the granulocyte colony-stimulating factor receptor
The Sweet Syndrome during Therapy with Granulocyte Colony-stimulating Factor
John W. Park, Bhoomi Mehrotra, Bryan O. Barnett et al. · Annals of Internal Medicine · 1992 · 144 citations
Medicine, Hematology, Oncology +10